🔎 Trials Near Me

Home › Anxiety › NCT05962879

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

Recruiting

Who can join

Ages 14 to 19 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Currently enrolled in 9th through 12th grade and between the ages of 14 and 19
* Endorsed at least one psychotic experience
* Provided contact information
* Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18)
* Have a parent or legal guardian who is able and willing to participate in a parent session
* Competent and willing to provide written informed assent (if under the age of 18) or consent (if age 18 or older)
* Able to communicate in English

Exclusion Criteria:

* Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence
* Currently obtaining psychotherapeutic intervention

About the study

This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.

What is being tested

Sponsor: Massachusetts General Hospital · Participants: 70 · Started: Mar 22, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT05962879

Locations in the U.S.

MassachusettsMassachusetts General Hospital, Boston

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.